Lech Chrostek

1.9k total citations
131 papers, 1.4k citations indexed

About

Lech Chrostek is a scholar working on Epidemiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Lech Chrostek has authored 131 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 54 papers in Pathology and Forensic Medicine and 36 papers in Molecular Biology. Recurrent topics in Lech Chrostek's work include Liver Disease Diagnosis and Treatment (56 papers), Alcohol Consumption and Health Effects (50 papers) and Glycosylation and Glycoproteins Research (24 papers). Lech Chrostek is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Alcohol Consumption and Health Effects (50 papers) and Glycosylation and Glycoproteins Research (24 papers). Lech Chrostek collaborates with scholars based in Poland, United States and United Kingdom. Lech Chrostek's co-authors include Maciej Szmitkowski, Bogdan Cylwik, Wojciech Jelski, Ewa Gruszewska, Maciej Szmitkowski, Monika Gudowska-Sawczuk, Robert Flisiak, M Szmitkowski, B Zalewski and Z Puchałski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Lech Chrostek

126 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lech Chrostek Poland 21 539 408 370 224 188 131 1.4k
Josepmaria Argemí Spain 19 421 0.8× 429 1.1× 195 0.5× 229 1.0× 117 0.6× 82 1.2k
Aritz Lopategi Spain 14 520 1.0× 307 0.8× 121 0.3× 352 1.6× 101 0.5× 17 1.4k
F.A. Giannone Italy 18 359 0.7× 386 0.9× 146 0.4× 334 1.5× 116 0.6× 35 1.1k
María J. Iraburu Spain 17 357 0.7× 408 1.0× 146 0.4× 388 1.7× 69 0.4× 39 1.3k
Jee Hyun Lee South Korea 16 357 0.7× 445 1.1× 149 0.4× 279 1.2× 181 1.0× 67 1.6k
Masataka Okuno Japan 28 489 0.9× 862 2.1× 162 0.4× 457 2.0× 339 1.8× 97 2.2k
Eleonora Patsenker Switzerland 25 842 1.6× 488 1.2× 298 0.8× 862 3.8× 237 1.3× 40 2.2k
Xueke Zhao China 20 321 0.6× 522 1.3× 94 0.3× 255 1.1× 141 0.8× 58 1.2k
Xu Li China 25 414 0.8× 777 1.9× 75 0.2× 164 0.7× 135 0.7× 74 1.7k
Yuko Akazawa Japan 25 804 1.5× 538 1.3× 113 0.3× 261 1.2× 250 1.3× 115 2.3k

Countries citing papers authored by Lech Chrostek

Since Specialization
Citations

This map shows the geographic impact of Lech Chrostek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lech Chrostek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lech Chrostek more than expected).

Fields of papers citing papers by Lech Chrostek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lech Chrostek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lech Chrostek. The network helps show where Lech Chrostek may publish in the future.

Co-authorship network of co-authors of Lech Chrostek

This figure shows the co-authorship network connecting the top 25 collaborators of Lech Chrostek. A scholar is included among the top collaborators of Lech Chrostek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lech Chrostek. Lech Chrostek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gruszewska, Ewa, et al.. (2024). Serum galectin-9 concentration in patients with COVID-19. Clinica Chimica Acta. 558. 118924–118924. 1 indexed citations
2.
Chrostek, Lech, et al.. (2024). Acute-phase proteins as indicators of disease severity and mortality in COVID-19 patients. Scientific Reports. 14(1). 20360–20360. 2 indexed citations
3.
Chrostek, Lech, et al.. (2024). Procalcitonin and transferrin as a survival markers of patients with COVID-19. Clinica Chimica Acta. 558. 118882–118882. 1 indexed citations
4.
Cylwik, Bogdan, et al.. (2024). Diagnostic Usefulness of Serum Hyaluronic Acid in Patients with SARS-CoV-2 Infection. Journal of Clinical Medicine. 13(23). 7471–7471. 1 indexed citations
5.
Cylwik, Bogdan, et al.. (2023). The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC). Journal of Clinical Medicine. 12(24). 7552–7552. 6 indexed citations
6.
Gruszewska, Ewa, et al.. (2021). Liver function in COVID-19 infection. World Journal of Hepatology. 13(12). 1909–1918. 7 indexed citations
7.
Zbucka-Krętowska, Monika, Iwona Sidorkiewicz, Monika Zajkowska, et al.. (2019). Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis. Pathology & Oncology Research. 26(2). 791–800. 19 indexed citations
8.
Chrostek, Lech, Bogdan Cylwik, Ewa Gińdzieńska‐Sieśkiewicz, et al.. (2013). Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases. Rheumatology International. 34(3). 393–399. 18 indexed citations
9.
Chrostek, Lech, et al.. (2012). N-Latex CDT Results in Liver Diseases. Alcohol and Alcoholism. 47(4). 428–432. 10 indexed citations
10.
11.
Cylwik, Bogdan, et al.. (2010). Lipid-bound sialic acid in alcoholics participates in increased level of total sialic acid. Alcohol. 44(5). 457–462. 5 indexed citations
12.
Cylwik, Bogdan, Lech Chrostek, B Zalewski, A Dâbrowski, & Maciej Szmitkowski. (2007). Serum Total Sialic Acid in Differential Diagnostics of Jaundice Caused by Malignant and Nonmalignant Diseases: A ROC Curve Analysis. Digestive Diseases and Sciences. 52(9). 2317–2322. 3 indexed citations
13.
Jelski, Wojciech, Lech Chrostek, & Maciej Szmitkowski. (2007). The Activity of Class I, II, III, and IV of Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Pancreatic Cancer. Pancreas. 35(2). 142–146. 36 indexed citations
14.
Cylwik, Bogdan, et al.. (2005). Carbohydrate-deficient isoforms of transferrin (%CDT) and sialic acid (SA) in iron-deficiency anemia. Clinical & Laboratory Haematology. 27(5). 297–301. 4 indexed citations
15.
Jelski, Wojciech, B Zalewski, Lech Chrostek, & Maciej Szmitkowski. (2004). The Activity of Class I, II, III, and IV Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in Colorectal Cancer. Digestive Diseases and Sciences. 49(6). 977–981. 35 indexed citations
16.
Chrostek, Lech, Wojciech Jelski, Maciej Szmitkowski, & Z Puchałski. (2003). Gender‐related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. Journal of Clinical Laboratory Analysis. 17(3). 93–96. 73 indexed citations
17.
Chrostek, Lech & Maciej Szmitkowski. (2000). The Activity of Class I and II Alcohol Dehydrogenase Isoenzymes in the Sera of Patients with Liver Tumours. Clinical Chemistry and Laboratory Medicine (CCLM). 38(5). 409–412. 6 indexed citations
18.
Chrostek, Lech & Maciej Szmitkowski. (1998). Serum activities of classes I and II alcohol dehydrogenases in toxic liver damage. Clinica Chimica Acta. 271(2). 163–169. 2 indexed citations
19.
Chrostek, Lech & Maciej Szmitkowski. (1997). Activity of class I and II isoenzymes of alcohol dehydrogenase measured by a fluorometric method in the sera of patients with obstructive jaundice. Clinica Chimica Acta. 263(1). 117–122. 4 indexed citations
20.
Chrostek, Lech & Maciej Szmitkowski. (1995). Serum Class I and II Alcohol Dehydrogenase Activity During the Course of Viral Hepatitis. Clinical Chemistry and Laboratory Medicine (CCLM). 33(11). 825–830. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josepmaria Argemí Breakdown of academic impact, for papers by Aritz Lopategi Breakdown of academic impact, for papers by F.A. Giannone Breakdown of academic impact, for papers by María J. Iraburu Breakdown of academic impact, for papers by Jee Hyun Lee Breakdown of academic impact, for papers by Masataka Okuno Breakdown of academic impact, for papers by Eleonora Patsenker Breakdown of academic impact, for papers by Xueke Zhao Breakdown of academic impact, for papers by Xu Li Breakdown of academic impact, for papers by Yuko Akazawa
Rankless by CCL
2026